Search published articles


Showing 2 results for جوشقانی

, , , , ,
Volume 7, Issue 1 (8-2010)
Abstract

Abstract Background and Objective: Diabetes mellitus and its complications are the leading factors of mortality and morbidity in human. This study aimed at determining the prevalence of Diabetes Mellitus (DM) and some related factors in the north of Iran. Material and Methods: This crossectional–descriptive study was carried out on 1998 cases (1000 men and 998 women) aged 25- 65 years old. The subjects were chosen by stratified sampling. A socioeconomic questionnaire was filled out. We meseared Fasting Blood Sugar (FBS) and Anthropometric indexes such as height, weight and waist. Diabetes mellitus (DM) was defined when Fasting Blood Sugar (FBS) was equal or over 126 mg/dl. Data was analyzed by SPSS software, using Chi Square and T.test (P<0.05). Results: The mean age is 44.2 years. FBS of male is 94.51±32.91 mg/dl and of female is 98.2±40.1. The prevalence of diabetes mellitus (DM) is 8.3% [(men = 6.8% and women =9.7%), (urban =10.5% and villages=6.4%0)]. There is a positive correlation between FBS and age, waist circumference and BMI (P=0.01). Blood glucose is controlled by diet and physical activity 64.1% and 24.2%, respectively. Conclusion: One out of twelve of adults in Golestan province suffer from DM. Obesity, Overweight and central obesity are coexisting problems with DM. it is a necessity to present a protocol based on screening and education of DM patients.
Dr Mohammad Mojerloo, Alireza Shariati, Hamid Asayesh, Dr Hamid Reza Joshaghani, Moslem Hesam, Hossein Nasiri, Mahdis Shariati, Maryam Safarian,
Volume 10, Issue 0 (Supplementary 2013)
Abstract

  Background and Objective: anemia is one of the main problems of chronic renal failure patients undergone Hemodialysis and erythropoietin is not effective for these patients. Since Vitamin C deficiency in Hemodialysis patients is common, this study was performed to compare the effect of intravenous and oral ascorbic acid consumption on anemia in Hemodialysis patients.

  Material and Methods: this clinical trial was conducted on 75 patients, selected via convenience sampling and including criteria (hemoglobin, 11mg/dl ferritin, 100ug/L transferring saturation, < 20%). The subjects were randomly assigned to three equal groups of control , oral ascorbic acid (POAA) and intravenous ascorbic acid (IVAA) After each every-other-day dialysis performed for eight weeks, the patients of IVAA group were given 300mg intravenous vitamin C and the ones of POAA group given 500mg vitamin C orally. The Plasma iron with chemical method, total iron-binding capacity (TIBC) and ferritin level with indirect method, hemoglobin with cell counter and transferring saturation (TSAT) with related formula were measured. Using a checklist, the data of demographic, laboratory results and side effects were recorded and analyzed by SPSS-13, using ANOVA and scheffe post-hoc test (p≤ 0.05).

  

  Results: the baseline hemoglobin, serum iron, ferritin, TIBC and TSAT in three groups were not different significantly. After intervention, the hemoglobin level of IVAA group( 20.1g/dl ) and in POAA group (0.99g/dl) were increased compared to control group(P>0.001). the mean of hemoglobin in IVAA was significantly more than POAA (P>0.05).

  

  Conclusion: based on the results, the use of oral and intravenous vitamin C can be effective in the anemia caused by iron deficiency, especially vitamin C injection that is more beneficial.

 



Page 1 from 1     

© 2026 CC BY-NC 4.0 | Journal of Research Development in Nursing and Midwifery

Designed & Developed by : Yektaweb